{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Darboe F"],"funding":["European and Developing Countries Clinical Trials Partnership","European Research Council","Medical Research Council"],"pagination":["1092"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5599783"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["8"],"pubmed_abstract":["Bacillus Calmette-Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is important for the development of optimal vaccination strategies. We set out to assess the effect of vaccination with BCG Russia of 6-week-old infants on <i>in vitro</i> reactivity to a panel of toll-like receptor (TLR) agonists (TLR2, 4, and 7/8) and heat-killed pathogens [<i>Streptococcus pneumoniae, Candida albicans</i> (CA), and <i>Escherichia coli</i>], and antibody responses to other EPI vaccines compared to BCG naïve infants. We observed no effect of BCG vaccination on innate (TNF-α) or T"],"journal":["Frontiers in immunology"],"pubmed_title":["Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guerin Russia Vaccination."],"pmcid":["PMC5599783"],"funding_grant_id":["MC_U190085854","310372","MC_U190071468","G0701291"],"pubmed_authors":["Sutherland JS","Rowland-Jones SL","Reynolds J","Darboe F","Hossin S","Plebanski M","Flanagan KL","Adetifa JU","Netea MG"],"additional_accession":[]},"is_claimable":false,"name":"Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guerin Russia Vaccination.","description":"Bacillus Calmette-Guérin (BCG), the only licensed vaccine against tuberculosis, has been shown to provide heterologous protection against unrelated pathogens and enhance antibody responses to several routine expanded program on immunization (EPI) vaccines. Understanding these heterologous effects is important for the development of optimal vaccination strategies. We set out to assess the effect of vaccination with BCG Russia of 6-week-old infants on <i>in vitro</i> reactivity to a panel of toll-like receptor (TLR) agonists (TLR2, 4, and 7/8) and heat-killed pathogens [<i>Streptococcus pneumoniae, Candida albicans</i> (CA), and <i>Escherichia coli</i>], and antibody responses to other EPI vaccines compared to BCG naïve infants. We observed no effect of BCG vaccination on innate (TNF-α) or T","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017","modification":"2025-04-05T14:18:39.335Z","creation":"2019-03-27T02:56:27Z"},"accession":"S-EPMC5599783","cross_references":{"pubmed":["28951731"],"doi":["10.3389/fimmu.2017.01092"]}}